![4-[(4-Methylpiperazin-1-yl)methyl] searbhag benzoic dihydrochloride CAS 106261-49-8 Imatinib Mesylate Eadar-mheadhanach Àrd Purity Ìomhaigh sònraichte](https://www.ruifuchemical.com/uploads/d1fa2a19.jpg)
4-[(4-Methylpiperazin-1-yl)methyl] searbhag benzoic dihydrochloride CAS 106261-49-8 Imatinib Mesylate Eadar-mheadhanach Àrd Purity
Solarachadh Malairteach Imatinib Mesylate agus Meadhanan Co-cheangailte:
Imatinib Mesylate CAS: 220127-57-1
N-(2-Methyl-5-nitrophenyl)-4-(pyridin-3-yl)pyrimidin-2-amine CAS: 152460-09-8
N-(5-Amino-2-methylphenyl)-4-(3-pyridyl)-2-pyrimidinea CAS: 152460-10-1
4-[(4-Methylpiperazin-1-yl)methyl] searbhag benzoic dihydrochloride CAS: 106261-49-8
| Ainm Ceimigeach | 4-[(4-Methylpiperazin-1-il)methyl] searbhag benzoic dihydrochloride |
| Co-fhaclan | Imatinib Mesylate eadar-mheadhanach a |
| Àireamh CAS | 106261-49-8 |
| Àireamh CAT | RF-PI229 |
| Inbhe Stoc | Ann an stoc, ìre toraidh suas gu tonna |
| Foirmle Molecular | C13H20Cl2N2O2 |
| Cuideam Molecular | 307.22 |
| Rubha leaghaidh | 305.0 ~ 307.0 ℃ |
| Fuasgladh | Soluble ann an uisge |
| Brand | Ceimigeach Ruifu |
| Nì | Sònrachaidhean |
| Coltas | Pùdar geal gu cha mhòr geal gu Crystal |
| Purity / Modh Mion-sgrùdadh | ≥98.0% (HPLC) |
| Call air tiormachadh | ≤0.50% |
| Fuigheall air lasadh | ≤0.50% |
| Neo-dhìomhaireachd iomlan | ≤2.0% |
| Impurity singilte as àirde | ≤1.0% |
| Inbhe deuchainn | Inbhe Iomairt |
| Cleachdadh | Cungaidh-leigheis eadar-mheadhanach de Imatinib Mesylate (CAS: 220127-57-1) |
Pacaid: Botal, poca foil alùmanum, druma cairt-bhòrd, 25kg / Drum, no a rèir riatanas luchd-ceannach.
Suidheachadh stòraidh:Bùth ann an soithichean dùinte ann an àite fionnar is tioram;Dìon bho sholas, taiseachd agus plàighean.
Is e Shanghai Ruifu Chemical Co., Earr am prìomh neach-dèanamh agus solaraiche de 4-[(4-Methylpiperazin-1-yl) methyl] searbhag benzoic dihydrochloride (CAS: 106261-49-8) le càileachd àrd.Tha ena eadar-mheadhanach mar as trice ann an synthesis Imatinib Mesylate (CAS: 220127-57-1).Tha Imatinib Mesylate na neach-dìon tyrosine kinase, gu math sònraichte airson BCR-ABL, droga beòil airson làimhseachadh euslaintich inbheach le leucemia myeloid cronosome cromosoma Philadelphia (CML) anns an ìre dhian agus cruthan sònraichte de leucemia lymphoblastic acute (ALL), air a luathachadh. ìre agus ìre leantainneach às deidh fàilligeadh interferon therapy.
![4-[(4-Methylpiperazin-1-yl)methyl] searbhag benzoic dihydrochloride CAS 106261-49-8 Imatinib Mesylate Eadar-mheadhanach Àrd Purity](https://www.ruifuchemical.com/uploads/d1fa2a19-300x300.jpg)